Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-20-000127
Filing Date
2020-02-14
Accepted
2020-02-14 16:03:07
Documents
4
Group Members
ANDREW H. WARFORDLEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss165785_sc13g.htm SC 13G 84220
2 POWER OF ATTORNEY ss165785_ex24a.htm EX-24.A 2648
3 POWER OF ATTORNEY ss165785_ex24b.htm EX-24.B 2911
4 JOINT FILING AGREEMENT ss165785_ex99a.htm EX-99.A 13773
  Complete submission text file 0000947871-20-000127.txt   105168
Mailing Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201
Business Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

EIN.: 000000000 | State of Incorp.: TX
Type: SC 13G

Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88393 | Film No.: 20619301
SIC: 2836 Biological Products, (No Diagnostic Substances)